Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEING: TAF/FTC Switch for Bone Health in HIV+ Women
NCT02815566Phase 4Completed
- Sponsor
- University Health Network
- Start
- Sep 2017
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of emtricitabine + tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by University Health Network. Started Sep 2017; status: completed.
02
Drugs
emtricitabine + tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02815566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02815566.